CPM
GILD icon

Connective Portfolio Management’s Gilead Sciences GILD Stock Holding History

Connective Portfolio Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,325
Closed -$830K – 55
2024
Q1 		$830K Hold
11,325
– – 1.46% 31
2023
Q4 		$917K Hold
11,325
– – 1.87% 23
2023
Q3 		$849K Hold
11,325
– – 2.58% 20
2023
Q2 		$873K Sell
11,325
-445
-4% -$35.5K 2.16% 23
2023
Q1 		$977K Sell
11,770
-20,000
-63% -$1.66M 3.1% 14
2022
Q4 		$2.73M Buy
31,770
+20,000
+170% +$1.58M 5.82% 1
2022
Q3 		$726K Buy
+11,770
New +$742K 2.31% 19

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Connective Portfolio Management's GILD Position: Q2 2024 in Review

Connective Portfolio Management sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 11,325 shares — an estimated $830K sold.

Connective Portfolio Management first reported a position in GILD in Q3 2022 and held it in 7 quarters. The position peaked at $2.73M in Q4 2022. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • Connective Portfolio Management reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
  • Connective Portfolio Management sold 11,325 Gilead Sciences shares in Q2 2024, an estimated $830K.
  • Connective Portfolio Management first reported a position in Gilead Sciences in Q3 2022 and held it in 7 quarters.
  • Connective Portfolio Management's Gilead Sciences position peaked at $2.73M in Q4 2022.
  • 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Connective Portfolio Management's 13F filing for Q2 2024, filed 30 Jul 2024.